Your browser doesn't support javascript.
loading
Epidemiology of multiple sclerosis in Santiago de Compostela (Spain).
Costa Arpín, Eva; Naveiro Soneira, Javier; Lema Bouzas, Manuela; González Quintela, Arturo; Prieto González, José María.
Afiliação
  • Costa Arpín E; Neurology Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
  • Naveiro Soneira J; Neurology Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
  • Lema Bouzas M; Neurology Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
  • González Quintela A; Intern Medicine Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
  • Prieto González JM; Neurology Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
Acta Neurol Scand ; 142(3): 267-274, 2020 Sep.
Article em En | MEDLINE | ID: mdl-32392359
ABSTRACT

OBJECTIVES:

To analyze the frequency and demographic characteristics of multiple sclerosis (MS) in the Council of Santiago de Compostela (SPAIN). MATERIAL AND

METHODS:

The patients diagnosed with MS according to the McDonald 2010 diagnostic criteria were identified within the population of the District of Santiago de Compostela. Several sources were used (records and databases from Hospital, General Practitioners, Private Clinics, and the MS Patients Association). Demographic and clinical data were obtained from the electronic files.

RESULTS:

The incidence of MS between 2010 and 2015 was 8/100 000/year (95% CI 6-10), and the prevalence on December 31, 2015, was 152/100 000 (95% CI 127-176). The age-standardized prevalence (using the European Standard Population 2013) was 137 (95% CI 114-159) and the incidence of 7 (95% CI 2-12). The femalemale ratio was 1.84, the mean age at the first symptom was 32.23 years, the diagnosis was delayed 3.12 years, and the mean EDSS was 2.82. 71.17% had relapsing-remitting MS, 16.55% secondary progressive MS, 7.59% primary progressive MS, and 0.69% progressive relapsing MS. A disease-modifying treatment was established in 62.76% of patients in a mean of 1.96 years after the diagnosis.

CONCLUSIONS:

The northwest of Spain is a high-risk area for MS, with frequencies similar to other Atlantic regions and higher than the rest of the country.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Esclerose Múltipla Tipo de estudo: Diagnostic_studies / Incidence_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Acta Neurol Scand Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Esclerose Múltipla Tipo de estudo: Diagnostic_studies / Incidence_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Acta Neurol Scand Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha